| Literature DB >> 28195161 |
Peiru Wang1,2, Min Sun1, Jianwei Ren3, Zora Djuric3, Gary J Fisher1, Xiuli Wang2, Yong Li1.
Abstract
Altering theEntities:
Mesh:
Substances:
Year: 2017 PMID: 28195161 PMCID: PMC5307384 DOI: 10.1038/srep42641
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Calibration curves of fatty acid standards.
| Fatty acids | Calibration curve equation | Coefficient correlation (r2) | Intra-day RSD% | Inter-day RSD% |
|---|---|---|---|---|
| LAA (12; 0) | y = 0.0549x − 0.0607 | 0.9969 | 4.55 | 8.87 |
| MA (14; 0) | y = 0.0539x + 0.0340 | 0.9930 | 5.32 | 6.27 |
| PA (16; 0) | y = 0.0994x − 0.0458 | 0.9988 | 7.64 | 11.60 |
| OA (18; 1 n-9) | y = 0.0596x + 0.0531 | 0.9952 | 8.95 | 11.70 |
| LA (18; 2 n-6) | y = 0.0319x − 0.0007 | 0.9948 | 6.52 | 14.73 |
| ALA(18; 3 n-3) | y = 0.1331x − 0.0569 | 0.9959 | 7.67 | 12.86 |
| DGLA (20; 3 n-6) | y = 0.2217x − 0.0268 | 0.9975 | 6.71 | 9.44 |
| AA (20; 4 n-6) | y = 0.2663x + 0.0915 | 0.9966 | 5.09 | 9.67 |
| EPA (20; 5 n-3) | y = 0.1431x − 0.0113 | 0.9961 | 8.22 | 10.71 |
| DPA (22; 5 n-3) | y = 0.0902x + 0.0715 | 0.9938 | 8.95 | 11.50 |
| DHA (22; 6 n-3) | y = 0.0771x − 0.0684 | 0.9933 | 7.20 | 12.00 |
Fatty acid composition (in mole %) of experimental diets.
| Diet | Control diet | Fish oil diet |
|---|---|---|
| LAA (12; 0) | 16.2 ± 0.9 | 12.6 ± 0.1* |
| MA (14; 0) | 8.5 ± 0.3 | 8.4 ± 0.0 |
| PA (16; 0) | 14.6 ± 0.6 | 15.3 ± 0.1 |
| OA (18; 1 n-9) | 45.1 ± 0.5 | 33.5 ± 0.4* |
| LA (18; 2 n-6) | 15.9 ± 0.4 | 15.2 ± 0.5 |
| ALA (18; 3 n-3) | 1.3 ± 0.1 | 1.4 ± 0.2 |
| DGLA (20; 3 n-6) | U.D. | U.D. |
| AA (20; 4 n-6) | U.D. | 1.2 ± 0.4 |
| EPA (20; 5 n-3) | U.D. | 6.9 ± 0.4 |
| DPA (22; 5 n-3) | U.D. | 1.7 ± 0.1 |
| DHA (22; 6 n-3) | U.D. | 6.2 ± 0.9 |
| LA/ALA | 11.5 | 10.7 |
U.D.: undetectable. Data shown is mean and SEM for five different aliquots of diets. *Asterisk indicates p < 0.05 when comparing the fish oil and control diet.
Skin fatty acid composition (mole %) after feeding experimental diets for 2, 4 and 8 weeks (n = 5).
| Mouse Skin | 2-week | 4-week | 8-week | |||
|---|---|---|---|---|---|---|
| control | fish oil | control | fish oil | control | fish oil | |
| LAA (12; 0) | 1.7 ± 0.5 | 1.9 ± 0.3 | 3.9 ± 0.2 | 3.9 ± 0.5 | 3.5 ± 0.3 | 2.9 ± 0.3 |
| MA (14; 0) | 3.0 ± 0.5 | 3.3 ± 0.3 | 3.5 ± 0.3 | 3.5 ± 0.3 | 3.4 ± 0.2 | 3.0 ± 0.4 |
| PA (16; 0) | 18.2 ± 2.1 | 16.5 ± 1.3 | 13.3 ± 1.2 | 13.2 ± 1.1 | 15.4 ± 0.9 | 13.2 ± 1.1 |
| OA (18; 1 n-9) | 50.5 ± 3.6 | 47.3 ± 2.0 | 51.4 ± 2.3 | 45.1 ± 3.4 | 53.1 ± 2.1 | 47.1 ± 2.0 |
| LA (18; 2 n-6) | 21.4 ± 2.8 | 19.0 ± 2.6 | 20.2 ± 2.0 | 16.5 ± 1.2 | 18.0 ± 1.3 | 16.0 ± 1.1 |
| ALA (18; 3 n-3) | 0.9 ± 0.2 | 1.2 ± 0.2 | 0.9 ± 0.2 | 1.4 ± 0.2 | 0.9 ± 1.2 | 1.3 ± 1.1 |
| DGLA (20; 3 n-6) | 0.4 ± 0.0 | 0.4 ± 0.1 | 0.3 ± 0.1 | 0.2 ± 0.0 | 0.4 ± 0.1 | 0.4 ± 0.1 |
| AA (20; 4 n-6) | 2.8 ± 0.5 | 2.1 ± 0.3 | 3.5 ± 0.6 | 1.7 ± 0.2 | 3.0 ± 0.4 | 1.6 ± 0.2 |
| EPA (20; 5 n-3) | 0.4 ± 0.1 | 2.2 ± 0.2 | 0.5 ± 0.1 | 3.8 ± 0.4 | 0.5 ± 0.1 | 3.2 ± 0.2 |
| DPA (22; 5 n-3) | 0.6 ± 0.1 | 2.5 ± 0.3 | 0.6 ± 0.1 | 4.5 ± 1.4 | 0.7 ± 0.1 | 4.5 ± 0.5 |
| DHA (22; 6 n-3) | 0.7 ± 0.1 | 4.0 ± 0.5 | 0.8 ± 0.2 | 6.9 ± 1.3 | 0.7 ± 0.0 | 6.5 ± 0.4 |
Serum fatty acid composition (mole %) after feeding experimental diets for 8 weeks (n = 5).
| Mouse Serum | Control | Fish oil |
|---|---|---|
| LAA (12; 0) | 2.5 ± 0.1 | 2.6 ± 0.3 |
| MA (14; 0) | 3.4 ± 0.5 | 3.7 ± 0.5 |
| PA (16; 0) | 29.2 ± 0.6 | 30.3 ± 1.2 |
| OA (18; 1 n-9) | 28.4 ± 1.2 | 18.0 ± 1.1 |
| LA (18; 2 n-6) | 14.3 ± 0.4 | 13.2 ± 0.5 |
| ALA (18; 3 n-3) | 0.4 ± 0.0 | 0.6 ± 0.1 |
| DGLA (20; 3 n-6) | 0.7 ± 0.0 | 1.0 ± 0.1 |
| AA (20;4 n-6) | 18.0 ± 1.2 | 8.3 ± 0.7 |
| EPA (20; 5 n-3) | 0.3 ± 0.0 | 9.0 ± 0.6 |
| DPA (22; 5 n-3) | 1.0 ± 0.1 | 4.6 ± 0.4 |
| DHA (22; 6 n-3) | 2.7 ± 0.2 | 10.2 ± 0.9 |
Fold-changes (fish oil versus control) of FAs in the skin and serum after feeding experimental diets for 8 weeks (n = 5).
| skin | serum | |
|---|---|---|
| Fish oil/Control | Fish oil/Control | |
| LAA (12; 0) | 0.9 ± 0.1 | 1.0 ± 0.1 |
| MA (14; 0) | 0.9 ± 0.1 | 1.1 ± 0.1 |
| PA (16; 0) | 0.9 ± 0.1 | 1.0 ± 0.0 |
| OA (18; 1 n-9) | 0.9 ± 0.0 | 0.6 ± 0.0** |
| LA (18; 2 n-6) | 0.9 ± 0.0 | 0.9 ± 0.0 |
| ALA (18; 3 n-3) | 1.4 ± 0.1 | 1.6 ± 0.1 |
| DGLA (20; 3 n-6) | 0.9 ± 0.1 | 1.4 ± 0.1* |
| AA (20; 4 n-6) | 0.5 ± 0.1 | 0.5 ± 0.0 |
| EPA (20; 5 n-3) | 7.1 ± 0.8 | 30.3 ± 1.2** |
| DPA (22; 5 n-3) | 6.7 ± 0.6 | 4.5 ± 0.5** |
| DHA (22; 6 n-3) | 8.9 ± 0.5 | 3.8 ± 0.2** |
*p < 0.05, **p < 0.01 when comparing fold-changes between the skin and serum presented in the Table 5.
Fatty acid composition (mole%) in human skin (n = 5).
| Human skin | |
|---|---|
| LAA (12; 0) | 1.4 ± 0.4 |
| MA (14; 0) | 2.7 ± 0.7 |
| PA (16; 0) | 22.3 ± 1.3 |
| OA (18; 1 n-9) | 50.1 ± 2.6 |
| LA (18; 2 n-6) | 18.4 ± 1.2 |
| ALA (18; 3 n-3) | 1.4 ± 0.4 |
| DGLA (20; 3 n-6) | 0.4 ± 0.1 |
| AA (20; 4 n-6) | 2.4 ± 0.7 |
| EPA (20; 5 n-3) | 0.4 ± 0.1 |
| DPA (22; 5 n-3) | 0.3 ± 0.0 |
| DHA (22; 6 n-3) | 0.8 ± 0.1 |